Currently, there are 365.24M common shares owned by the public and among those 290.69M shares have been available to trade.
The company’s stock has a 5-day price change of 0.95% and -10.65% over the past three months. BHC shares are trading -7.32% year to date (YTD), with the 12-month market performance down to -9.56% lower. It has a 12-month low price of $3.96 and touched a high of $11.46 over the same period. BHC has an average intraday trading volume of 1.61 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -2.37%, -7.07%, and 0.43% respectively.
Institutional ownership of Bausch Health Companies Inc (NYSE: BHC) shares accounts for 61.47% of the company’s 365.24M shares outstanding.
It has a market capitalization of $2.75B and a beta (3y monthly) value of 0.68. The earnings-per-share (ttm) stands at -$0.48. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.06% over the week and 3.35% over the month.
Earnings per share for the fiscal year are expected to increase by 7.76%, and 13.00% over the next financial year. EPS should shrink at an annualized rate of -0.37% over the next five years, compared to 32.76% over the past 5-year period.
Looking at the support for the BHC, a number of firms have released research notes about the stock. Piper Sandler stated their Underweight rating for the stock in a research note on August 02, 2024, with the firm’s price target at $9-$3. Raymond James coverage for the Bausch Health Companies Inc (BHC) stock in a research note released on July 10, 2024 offered a Mkt Perform rating with a price target of $8. Truist on their part issued Hold rating on July 29, 2022.
